HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evdoxia Rapti Selected Research

Evdoxia Rapti Research Topics

Disease

2COVID-19
01/2022 - 11/2020
2Critical Illness (Critically Ill)
11/2020 - 03/2010
1Thrombotic Microangiopathies
01/2021
1Infections
11/2020
1Pulmonary Arterial Hypertension
09/2020
1Hemorrhage
12/2018
1Atrial Fibrillation
12/2018
1Septic Shock (Toxic Shock Syndrome)
03/2010
1Sepsis (Septicemia)
03/2010
1Thrombophilia
03/2010
1Essential Thrombocythemia
01/2008
1Thrombocytosis (Thrombocythemia)
01/2008
1Venous Thrombosis (Deep-Vein Thrombosis)
06/2007
1Venous Thromboembolism
06/2007

Drug/Important Bio-Agent (IBA)

3Hemostatics (Antihemorrhagics)IBA
11/2020 - 03/2010
3Plasminogen Activators (Plasminogen Activator)IBA
11/2020 - 06/2007
2Complement System Proteins (Complement)IBA
01/2022 - 01/2021
2AnticoagulantsIBA
11/2020 - 12/2018
2ThrombinFDA Link
11/2020 - 12/2018
1antineoplaston A10 (A 10)IBA
11/2020
1RivaroxabanIBA
12/2018
1apixabanIBA
12/2018
1SteroidsIBA
03/2010
1factor V LeidenIBA
03/2010
1Fibrinogen (Factor I)FDA Link
03/2010
1A-factor (Streptomyces)IBA
03/2010
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2008

Therapy/Procedure

1Therapeutics
11/2020